| Value | ₹100.0 Cr |
|---|
BSE filing, NSE: SANGAMIND. Summary written from the filing by ALFA Finder's alert engine.
Sangam (India) Ltd: key numbers
- Share price
- ₹611.00
- Market cap
- ₹3,070 Cr
- Revenue (annual)
- ₹3,235 Cr
- Net profit (annual)
- ₹82.60 Cr
- P/E (TTM)
- 20.2×Sector 33.3×
- Promoter holding
- 70.52%+0.00% QoQ
- FII holding
- 2.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sangam (India) Ltd
All →Sangam (India) Other Announcement
Sangam (India) Limited submitted its Monitoring Agency Report for the quarter ended September 2026. The report tracks utilization of Rs. 100.00 Crore raised via preferential warrant issuance.
Sangam (India) Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹1,045 Cr (+33.0% YoY), PAT ₹53 Cr (+130.9%), EBITDA margin 12.1%. H1 FY27 PAT already exceeds full FY26.
Sangam (India) Q2 FY27 Results: Net Profit ₹53.4 Cr, Up 131.2% YoY
Sangam (India) Ltd reported revenue from operations of ₹1,045 Cr (+33.0% YoY) and net profit of ₹53.4 Cr (+131.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹53.4 Cr · +131.2% YoY
Sangam (India) Board Meeting Date
Sangam India Ltd scheduled its board meeting for 4 November 2026 to approve unaudited Q2 results. No financial figures or decisions are reported in this prior intimation.
Sangam (India) Credit Rating
India Ratings upgraded Sangam (India)'s bank loan facilities to IND A/Stable from IND A-. Fresh bank facilities were also assigned the same rating.
Sangam (India) Annual General Meeting
Sangam (India) Limited announced the successful completion of a postal ballot, approving the appointment of Mr. Ranjan Jagetia as an Independent Director.
Other capital structure change announcements
All →Jyothy Labs Capital Structure Change
Jyothy Labs' board approved a Rs 147 Crore share buyback via tender offer at Rs 215 per share. The record date is November 11, 2026.
- Value
- ₹147.0 Cr
Evonile Pharma Capital Structure Change
Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as record date for a partly paid rights issue of 1,02,87,832 shares at Rs.860 each. Issue size is Rs.8,847.54 Million, with issue opening November 19, 2026.
- Value
- ₹884.8 Cr
- Execution
- Issue opening 19 Nov 2026 to closing 3 Dec 2026; listing on or about 9 Dec 2026
Share India Securities Capital Structure Change
Share India Securities allotted 44,02,000 equity shares under its Silverleaf Capital amalgamation scheme. It also granted 3,80,500 employee stock options under ESOS-II.
Arvaya Healthcare Capital Structure Change
Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.
- Value
- ₹210.0 Cr
Mittal Life Style Capital Structure Change
Mittal Life Style set 15 December 2026 as the record date for a 10:1 consolidation of its equity shares. No cash is paid.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ approved final terms of its Rs 40 crore rights issue at Rs 25 per share. Issue runs 19 November to 3 December 2026.
- Value
- ₹40.00 Cr